NRx Pharmaceuticals, Inc.

NasdaqCM NRXP

NRx Pharmaceuticals, Inc. Share Price on January 14, 2025: USD 5.10

NRx Pharmaceuticals, Inc. Share Price is USD 5.10 on January 14, 2025, a 19.72% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

NRx Pharmaceuticals, Inc. 52-week high Share Price is USD 7.01 on March 06, 2024, which is 37.45% above the current Share Price.
NRx Pharmaceuticals, Inc. 52-week low Share Price is USD 1.16 on November 14, 2024, which is -77.25% below the current Share Price.
NRx Pharmaceuticals, Inc. average Share Price for the last 52 weeks is USD 2.84.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqCM: NRXP

NRx Pharmaceuticals, Inc.

CEO	Dr. Jonathan C. Javitt M.D., M.P.H.
IPO Date	Dec. 4, 2017
Location	United States
Headquarters	1201 Orange Street
Employees	2
Sector	Health Care
Industries Pharmaceuticals Clinical Trials

Description

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

Key trends

Past 5 years